Skip to main content
Log in

Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Ro 64-6198, the prototypical non-peptide nociceptin/orphanin FQ peptide (NOP) receptor agonist, has potent anxiolytic-like effects in several preclinical models and species. However the effects of Ro 64-6198 on distinctive anxiety-provoking conditions related to unconditioned conflict behavior as well as its role in despair-like behavior remain to be addressed.

Objective

Here we examined the effects of Ro 64-6198 on unconditioned conflict anxiety using stimuli with different salience and on regulation of autonomic reactivity and compared these to the effects of benzodiazepine receptor agonists. We also addressed the potential effects of Ro 64-6198 on despair-like behavior.

Materials and methods

Ro 64-6198 (0.1 to 10 mg/kg i.p.) and either diazepam or chlordiazepoxide were tested in the Vogel conflict punished drinking test (VCT) in Sprague Dawley rats, in the social approach–avoidance (SAA) test in Lewis rats, in the novelty-induced hypophagia (NIH) in C57BL/6J mice, and in stress-induced hyperthermia in NMRI mice, as well as in the forced swim test (FST) in Sprague Dawley rats and the tail suspension test (TST) in C57BL/6J mice.

Results

Ro 64-6198 (0.3 to 3 mg/kg) dose-dependently produced anxiolytic-like effects in the VCT, SAA, NIH, and SIH, similar to benzodiazepine receptor agonists. Ro 64-6198 did not alter immobility time in the FST and TST.

Conclusions

Ro 64-6198 produced marked anxiolytic-like effects in response to a variety of mild to strong anxiogenic stimuli, whereas it did not facilitate depression-related behaviors. This data extend previous literature suggesting that NOP receptors are a viable target for the treatment of anxiety disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Adriaan Bouwknecht J, Olivier B, Paylor RE (2007) The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse. Neurosci Biobehav Rev 31:41–59

    Article  PubMed  CAS  Google Scholar 

  • Basso AM, Gallagher KB, Mikusa JP, Rueter LE (2011) Vogel conflict test: sex differences and pharmacological validation of the model. Behav Brain Res 218:174–83

    Article  PubMed  Google Scholar 

  • Bongsebandhu-phubhakdi S, Manabe T (2007) The neuropeptide nociceptin is a synaptically released endogenous inhibitor of hippocampal long-term potentiation. J Neurosci 27:4850–8

    Article  PubMed  CAS  Google Scholar 

  • Cavallini S, Marino S, Beani L, Bianchi C, Siniscalchi A (2003) Nociceptin inhibition of acetylcholine efflux from different brain areas. Neuroreport 14:2167–70

    Article  PubMed  CAS  Google Scholar 

  • Chee MJ, Price CJ, Statnick MA, Colmers WF (2011) Nociceptin–orphanin F/Q suppresses the excitability of neurons in the ventromedial nucleus of the hypothalamus. J Physiol 589(Pt 13):3103–14

    Article  PubMed  CAS  Google Scholar 

  • Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP (2007) Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Curr Drug Targets 8:117–35

    Article  PubMed  CAS  Google Scholar 

  • Ciccocioppo R, Biondini M, Antonelli L, Wichmann J, Jenck F, Massi M (2002) Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198. Psychopharmacology (Berl) 161:113–9

    Article  CAS  Google Scholar 

  • Ciccocioppo R, Cippitelli A, Economidou D, Fedeli A, Massi M (2004) Nociceptin/orphanin FQ acts as a functional antagonist of corticotropin-releasing factor to inhibit its anorectic effect. Physiol Behav 82:63–8

    Article  PubMed  CAS  Google Scholar 

  • Cryan JF, Holmes A (2005) The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4:775–90

    Article  PubMed  CAS  Google Scholar 

  • Dautzenberg FM, Wichmann J, Higelin J, Py-Lang G, Kratzeisen C, Malherbe P, Kilpatrick GJ, Jenck F (2001) Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo. J Pharmacol Exp Ther 298:812–9

    PubMed  CAS  Google Scholar 

  • Dawe KL, Wakerley JB, Fulford AJ (2010) Nociceptin/orphanin FQ and the regulation of neuronal excitability in the rat bed nucleus of the stria terminalis: interaction with glucocorticoids. Stress 13:516–27

    PubMed  CAS  Google Scholar 

  • Dulawa SC, Hen R (2005) Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 29:771–83

    Article  PubMed  CAS  Google Scholar 

  • Duzzioni M, Duarte FS, Leme LR, Gavioli EC, De Lima TC (2011) Anxiolytic-like effect of central administration of NOP receptor antagonist UFP-101 in rats submitted to the elevated T-maze. Behav Brain Res 222:206–211

    Article  PubMed  CAS  Google Scholar 

  • Economidou D, Fedeli A, Martin Fardon R, Weiss F, Massi M, Ciccocioppo R (2006) Effect of novel nociceptin/orphanin FQ–NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats. Peptides 27:3299–3206

    Article  PubMed  CAS  Google Scholar 

  • Fernandez F, Misilmeri MA, Felger JC, Devine DP (2004) Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety. Neuropsychopharmacology 29:59–71

    Article  PubMed  CAS  Google Scholar 

  • File SE (1991) The biological basis of anxiety. In: Meltzer HY, Nerozzi D (eds) Current practices and the future developments in the pharmacotherapy of mental disorders. Elsevier, Amsterdam, pp 159–165

  • Fornari RV, Soares JC, Ferreira TL, Moreira KM, Oliveira MG (2008) Effects of nociceptin/orphanin FQ in the acquisition of contextual and tone fear conditioning in rats. Behav Neurosci 122:98–106

    Article  PubMed  CAS  Google Scholar 

  • Friedman BH (2007) An autonomic flexibility-neurovisceral integration model of anxiety and cardiac vagal tone. Biol Psychol 74:185–99

    Article  PubMed  Google Scholar 

  • Gavioli EC, Calo G (2006) Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands. Naunyn Schmiedebergs Arch Pharmacol 372:319–30

    Article  PubMed  CAS  Google Scholar 

  • Gavioli EC, Marzola G, Guerrini R, Bertorelli R, Zucchini S, De Lima TC, Rae GA, Salvadori S, Regoli D, Calo G (2003) Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci 17:1987–90

    Article  PubMed  CAS  Google Scholar 

  • Gavioli EC, Rizzi A, Marzola G, Zucchini S, Regoli D, Calo G (2007) Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice. Peptides 28:1229–39

    Article  PubMed  CAS  Google Scholar 

  • Gavioli EC, Vaughan CW, Marzola G, Guerrini R, Mitchell VA, Zucchini S, De Lima TC, Rae GA, Salvadori S, Regoli D, Calo G (2004) Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch Pharmacol 369:547–53

    Article  PubMed  CAS  Google Scholar 

  • Goeldner C, Reiss D, Kieffer BL, Ouagazzal AM (2010) Endogenous nociceptin/orphanin-FQ in the dorsal hippocampus facilitates despair-related behavior. Hippocampus 20:911–6

    PubMed  CAS  Google Scholar 

  • Goeldner C, Reiss D, Wichmann J, Kieffer BL, Ouagazzal AM (2009) Activation of nociceptin opioid peptide (NOP) receptor impairs contextual fear learning in mice through glutamatergic mechanisms. Neurobiol Learn Mem 91:393–401

    Article  PubMed  CAS  Google Scholar 

  • Goeldner C, Reiss D, Wichmann J, Meziane H, Kieffer BL, Ouagazzal AM (2008) Nociceptin receptor impairs recognition memory via interaction with NMDA receptor-dependent mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in the hippocampus. J Neurosci 28:2190–8

    Article  PubMed  CAS  Google Scholar 

  • Griebel G, Perrault G, Sanger DJ (1999) Orphanin FQ, a novel neuropeptide with anti-stress-like activity. Brain Res 836:221–4

    Article  PubMed  CAS  Google Scholar 

  • Groenink L, van der Gugten J, Zethof T, van der Heyden J, Olivier B (1994) Stress-induced hyperthermia in mice: hormonal correlates. Physiol Behav 56:747–9

    Article  PubMed  CAS  Google Scholar 

  • Haller J, Bakos N (2002) Stress-induced social avoidance: a new model of stress-induced anxiety? Physiol Behav 77:327–32

    Article  PubMed  CAS  Google Scholar 

  • Higgins GA, Grottick AJ, Ballard TM, Richards JG, Messer J, Takeshima H, Pauly-Evers M, Jenck F, Adam G, Wichmann J (2001) Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function. Neuropharmacology 41:97–107

    Article  PubMed  CAS  Google Scholar 

  • Higgins GA, Kew JN, Richards JG, Takeshima H, Jenck F, Adam G, Wichmann J, Kemp JA, Grottick AJ (2002) A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory. Eur J Neurosci 15:911–22

    Article  PubMed  CAS  Google Scholar 

  • Hirao A, Imai A, Sugie Y, Tamura T, Shimokawa H, Toide K (2008a) Pharmacological properties of a novel nociceptin/orphanin FQ receptor agonist, 2-(3,5-dimethylpiperazin-1-yl)-1-[1-(1-methylcyclooctyl)piperidin-4-yl]-1H-benzimidazole, with anxiolytic potential. Eur J Pharmacol 579:189–95

    Article  PubMed  CAS  Google Scholar 

  • Hirao A, Imai A, Sugie Y, Yamada Y, Hayashi S, Toide K (2008b) Pharmacological characterization of the newly synthesized nociceptin/orphanin FQ-receptor agonist 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an anxiolytic agent. J Pharmacol Sci 106:361–8

    Article  PubMed  CAS  Google Scholar 

  • Jenck F, Moreau JL, Martin JR, Kilpatrick GJ, Reinscheid RK, Monsma FJ Jr, Nothacker HP, Civelli O (1997) Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci U S A 94:14854–8

    Article  PubMed  CAS  Google Scholar 

  • Jenck F, Ouagazzal AM, Pauly-Evers M, Moreau JL (2000a) OrphaninFQ: role in behavioral fear responses and vulnerability to stress? Mol Psychiatry 5:572–4

    Article  PubMed  CAS  Google Scholar 

  • Jenck F, Wichmann J, Dautzenberg FM, Moreau JL, Ouagazzal AM, Martin JR, Lundstrom K, Cesura AM, Poli SM, Roever S, Kolczewski S, Adam G, Kilpatrick G (2000b) A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc Natl Acad Sci U S A 97:4938–43

    Article  PubMed  CAS  Google Scholar 

  • Kamei J, Matsunawa Y, Miyata S, Tanaka S, Saitoh A (2004) Effects of nociceptin on the exploratory behavior of mice in the hole-board test. Eur J Pharmacol 489:77–87

    Article  PubMed  CAS  Google Scholar 

  • Kawahara Y, Hesselink MB, van Scharrenburg G, Westerink BH (2004) Tonic inhibition by orphanin FQ/nociceptin of noradrenaline neurotransmission in the amygdala. Eur J Pharmacol 485:197–200

    Article  PubMed  CAS  Google Scholar 

  • Klein S, Nicolas LB, Lopez-Lopez C, Jacobson LH, McArthur SG, Grundschober C, Prinssen EP (2010) Examining face and construct validity of a noninvasive model of panic disorder in Lister-hooded rats. Psychopharmacology (Berl) 211:197–208

    Article  CAS  Google Scholar 

  • Ko MC, Woods JH, Fantegrossi WE, Galuska CM, Wichmann J, Prinssen EP (2009) Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys. Neuropsychopharmacology 34:2088–96

    Article  PubMed  CAS  Google Scholar 

  • Kuzmin A, Madjid N, Johansson B, Terenius L, Ogren SO (2009) The nociceptin system and hippocampal cognition in mice: a pharmacological and genetic analysis. Brain Res 1305(Suppl):S7–19

    Article  PubMed  CAS  Google Scholar 

  • Lambert DG (2008) The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat Rev Drug Discov 7:694–710

    Article  PubMed  CAS  Google Scholar 

  • Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, Jones RM, Portoghese PS, Carlezon WA Jr (2003) Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323–30

    Article  PubMed  CAS  Google Scholar 

  • Manabe T, Noda Y, Mamiya T, Katagiri H, Houtani T, Nishi M, Noda T, Takahashi T, Sugimoto T, Nabeshima T, Takeshima H (1998) Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394:577–81

    Article  PubMed  CAS  Google Scholar 

  • McLeod RL, Jia Y, Fernandez X, Parra LE, Wang X, Tulshian DB, Kiselgof EJ, Tan Z, Fawzi AB, Smith-Torhan A, Zhang H, Hey JA (2004) Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig. Pharmacology 71:143–9

    Article  PubMed  CAS  Google Scholar 

  • McNaughton N, Corr PJ (2004) A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci Biobehav Rev 28:285–305

    Article  PubMed  Google Scholar 

  • Meis S (2003) Nociceptin/orphanin FQ: actions within the brain. Neuroscientist 9:158–68

    Article  PubMed  CAS  Google Scholar 

  • Meunier JC (1997) Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur J Pharmacol 340:1–15

    Article  PubMed  CAS  Google Scholar 

  • Millan MJ (2003) The neurobiology and control of anxious states. Prog Neurobiol 70:83–244

    Article  PubMed  CAS  Google Scholar 

  • Mollereau C, Mouledous L (2000) Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides 21:907–17

    Article  PubMed  CAS  Google Scholar 

  • Neal CR Jr, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Akil H, Watson SJ Jr (1999) Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol 412:563–605

    Article  PubMed  CAS  Google Scholar 

  • Nicolas LB, Klein S, Prinssen EP (2007) Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats. Psychopharmacology (Berl) 194:243–52

    Article  CAS  Google Scholar 

  • Nicolas LB, Kolb Y, Prinssen EP (2006) A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants. Eur J Pharmacol 547:106–15

    Article  PubMed  CAS  Google Scholar 

  • Nicolas LB, Prinssen EP (2006) Social approach-avoidance behavior of a high-anxiety strain of rats: effects of benzodiazepine receptor ligands. Psychopharmacology (Berl) 184:65–74

    Article  CAS  Google Scholar 

  • Obara I, Przewlocki R, Przewlocka B (2005) Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat. Pain 116:17–25

    Article  PubMed  CAS  Google Scholar 

  • Olivier B, Zethof T, Pattij T, van Boogaert M, van Oorschot R, Leahy C, Oosting R, Bouwknecht A, Veening J, van der Gugten J, Groenink L (2003) Stress-induced hyperthermia and anxiety: pharmacological validation. Eur J Pharmacol 463:117–32

    Article  PubMed  CAS  Google Scholar 

  • Olszewski PK, Levine AS (2004) Minireview: characterization of influence of central nociceptin/orphanin FQ on consummatory behavior. Endocrinology 145:2627–32

    Article  PubMed  CAS  Google Scholar 

  • Ramos A (2008) Animal models of anxiety: do I need multiple tests? Trends Pharmacol Sci 29:493–8

    Article  PubMed  CAS  Google Scholar 

  • Recker MD, Higgins GA (2004) The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-sp iro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a mu, kappa, and delta opioid receptor agonist cue. J Pharmacol Exp Ther 311:652–8

    Article  PubMed  CAS  Google Scholar 

  • Redrobe JP, Calo G, Regoli D, Quirion R (2002) Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test. Naunyn Schmiedebergs Arch Pharmacol 365:164–7

    Article  PubMed  CAS  Google Scholar 

  • Reinscheid RK (2006) The Orphanin FQ / Nociceptin receptor as a novel drug target in psychiatric disorders. CNS Neurol Disord Drug Targets 5:219–24

    Article  PubMed  CAS  Google Scholar 

  • Reiss D, Wichmann J, Tekeshima H, Kieffer BL, Ouagazzal AM (2008) Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine. Eur J Pharmacol 579:141–8

    Article  PubMed  CAS  Google Scholar 

  • Rizzi A, Gavioli EC, Marzola G, Spagnolo B, Zucchini S, Ciccocioppo R, Trapella C, Regoli D, Calo G (2007) Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9 -tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies. J Pharmacol Exp Ther 321:968–74

    Article  PubMed  CAS  Google Scholar 

  • Rizzi A, Molinari S, Marti M, Marzola G, Calo G (2011) Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. Neuropharmacology 60:572–9

    Article  PubMed  CAS  Google Scholar 

  • Schlicker E, Morari M (2000) Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system. Peptides 21:1023–9

    Article  PubMed  CAS  Google Scholar 

  • Sclafani A (2006) Enhanced sucrose and polycose preference in sweet “sensitive” (C57BL/6J) and “subsensitive” (129P3/J) mice after experience with these saccharides. Physiol Behav 87:745–56

    Article  PubMed  CAS  Google Scholar 

  • Shoblock JR (2007) The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity. CNS Drug Rev 13:107–36

    Article  PubMed  CAS  Google Scholar 

  • Spooren WP, Schoeffter P, Gasparini F, Kuhn R, Gentsch C (2002) Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). Eur J Pharmacol 435:161–70

    Article  PubMed  CAS  Google Scholar 

  • Tomasiewicz HC, Mague SD, Cohen BM, Carlezon WA Jr (2006) Behavioral effects of short-term administration of lithium and valproic acid in rats. Brain Res 1093:83–94

    Article  PubMed  CAS  Google Scholar 

  • Varty GB, Hyde LA, Hodgson RA, Lu SX, McCool MF, Kazdoba TM, Del Vecchio RA, Guthrie DH, Pond AJ, Grzelak ME, Xu X, Korfmacher WA, Tulshian D, Parker EM, Higgins GA (2005) Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species. Psychopharmacology (Berl) 182:132–43

    Article  CAS  Google Scholar 

  • Varty GB, Lu SX, Morgan CA, Cohen-Williams ME, Hodgson RA, Smith-Torhan A, Zhang H, Fawzi AB, Graziano MP, Ho GD, Matasi J, Tulshian D, Coffin VL, Carey GJ (2008) The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510). J Pharmacol Exp Ther 326:672–82

    Article  PubMed  CAS  Google Scholar 

  • Veening JG, Bouwknecht JA, Joosten HJ, Dederen PJ, Zethof TJ, Groenink L, van der Gugten J, Olivier B (2004) Stress-induced hyperthermia in the mouse: c-fos expression, corticosterone and temperature changes. Prog Neuropsychopharmacol Biol Psychiatry 28:699–707

    Article  PubMed  CAS  Google Scholar 

  • Vinkers CH, van Bogaert MJ, Klanker M, Korte SM, Oosting R, Hanania T, Hopkins SC, Olivier B, Groenink L (2008) Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigm. Eur J Pharmacol 585:407–25

    Article  PubMed  CAS  Google Scholar 

  • Vitale G, Arletti R, Ruggieri V, Cifani C, Massi M (2006) Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats. Peptides 27:2193–200

    Article  PubMed  CAS  Google Scholar 

  • Vitale G, Ruggieri V, Filaferro M, Frigeri C, Alboni S, Tascedda F, Brunello N, Guerrini R, Cifani C, Massi M (2009) Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats. Psychopharmacology (Berl) 207:173–89

    Article  CAS  Google Scholar 

  • Wei WZ, Xie CW (1999) Orphanin FQ suppresses NMDA receptor-dependent long-term depression and depotentiation in hippocampal dentate gyrus. Learn Mem 6:467–77

    Article  PubMed  CAS  Google Scholar 

  • Wichmann J, Adam G, Rover S, Hennig M, Scalone M, Cesura AM, Dautzenberg FM, Jenck F (2000) Synthesis of (1S,3aS)-8-(2,3,3a,4,5, 6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4. 5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties. Eur J Med Chem 35:839–51

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Séverine Bandinelli, Françoise Kahn and Sean Durkin for valuable technical assistance. All experiments described in this article were conducted at Roche, of which all authors are employees and declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric P. Prinssen.

Additional information

All experiments described in this article were conducted at Roche, of which all authors are employees and who declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goeldner, C., Spooren, W., Wichmann, J. et al. Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair. Psychopharmacology 222, 203–214 (2012). https://doi.org/10.1007/s00213-012-2636-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-012-2636-x

Keywords

Navigation